Im Cannabis Closes Previously Announced Acquisition Of Oranim Pharm, Jerusalem'S Leading Medical Cannabis Pharmacy
Acquiring Company
IM Cannabis Corp
Acquired Company
Oranim Pharm
Description
IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has completed the strategic acquisition of 51% of the rights in Oranim Pharm partnership ("Oranim Pharm"). Oranim Pharm is one of the largest pharmacies selling medical cannabis in Israel and the largest pharmacy selling medical cannabis in the Jerusalem area. The acquisition was completed through IMC Holdings Ltd. ("IMC Holdings"), a wholly-owned subsidiary of IM Cannabis Corp., following receipt of all requisite approvals, including from the Israeli Medical Cannabis Agency ("IMCA").
Quick answer
IM Cannabis Corp is acquiring Oranim Pharm, announced March 30, 2022. IM Cannabis Corp is based in Herzliya, Tel Aviv, Israel.
- How much did IM Cannabis Corp pay for Oranim Pharm?
- The deal value was not disclosed.
- What does IM Cannabis Corp do?
- IM Cannabis Corp. (IMC) is a leading medical cannabis company with operations in Israel and Germany.
- Where are IM Cannabis Corp and Oranim Pharm based?
- IM Cannabis Corp is based in Herzliya, Tel Aviv, Israel. Oranim Pharm is based in Israel.
- Who are the decision-makers at IM Cannabis Corp?
- Fundz holds 1 contact at IM Cannabis Corp. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Food and Beverage and Community And Lifestyle
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Conmed Announces Definitive Agreement To Acquire In2Bones Global, Inc. (May 4, 2022)
- Hikma Completes Acquisition Of Custopharm (April 21, 2022)
- Halozyme To Acquire Antares Pharma To Create A Specialty Product And Drug Delivery Leader (April 13, 2022)
- 22Nd Century Group (Nasdaq: Xxii) Acquires Gvb Biopharma, A Leading Hemp/Cannabis Company (May 13, 2022)
- Integrated Dental Organization Espire Dental Acquires Colorado-Based Meadows Dental Group (May 12, 2022)
- Pfizer To Acquire Biohaven Pharmaceuticals (May 10, 2022)
Who to call at IM Cannabis Corp, and when
When IM Cannabis Corp changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day IM Cannabis Corp raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at IM Cannabis Corp, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at IM Cannabis Corp. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment IM Cannabis Corp makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Oranim Pharm?
Oranim Pharm was acquired by IM Cannabis Corp, based in Herzliya. The deal was reported on March 30, 2022. IM Cannabis Corp. (IMC) is a leading medical cannabis company with operations in Israel and Germany. IM Cannabis Corp is publicly traded (IMCC) and operates in Other.
When did IM Cannabis Corp acquire Oranim Pharm?
IM Cannabis Corp's acquisition of Oranim Pharm was reported on March 30, 2022. IM Cannabis Corp. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Oranim Pharm do?
בית מרקחת אורנים פארם מתמחה באספקת קנאביס רפואי במרשם, משלוח קנאביס רפואי לבית הלקוח ומשלוח מגוון תרופות בהתאם למרשם. כנסו לאתר למידע נוסף. It is privately held, and is based in Israel.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.